Clinical decision support
First-draw intelligence for acute workflows, beginning with suspected Acute Coronary Syndrome.
Where routine blood test becomes precision medicine for clinical decision support, pharma biomarker intelligence, and CBC data asset.
RobotDreams is built on a simple insight: routine haematology data contains more signal than conventional CBC reporting exposes. THOLAN LAB adds intelligence to a workflow hospitals already use every day.
In emergency care, patients can wait hours for serial testing. In pharma, high-value blood signals are often invisible to conventional readouts. In population health, routine CBC data is treated as disposable instead of strategic.
THOLAN LAB uses data already generated by existing analysers and clinical workflows.
Raw cellular patterns are transformed into biomarker vectors and calibrated, auditable outputs.
The same core powers decision support, haematological cytomics/CDx, and long-term CBC data intelligence.
Each domain has a different time horizon, but they reinforce the same platform. Clinical use builds workflow credibility. Pharma expands the signal library. Data creates defensibility.
First-draw intelligence for acute workflows, beginning with suspected Acute Coronary Syndrome.
Biomarker discovery, patient stratification and companion-diagnostic co-development for pharma partners.
A structured, privacy-conscious haematology data asset linking cellular patterns to outcomes and response.
Every clinical deployment and pharma partnership can expand the reference base. The platform becomes more valuable as it is used.
Creates workflow credibility, evidence, and revenue from acute-care use cases.
Adds disease-specific and treatment-specific haematological signatures.
Builds a proprietary data asset that becomes harder to replicate over time.
RobotDreams is not a single-use diagnostic story. The company is designed around layered value creation: clinical revenue, pharma partnerships and long-term CBC data intelligence.
The team is structured around company leadership, specialist execution, and external clinical and legal guidance — matching the three horizons of THOLAN LAB: product, evidence, and scale.
Executive ownership across company building, operations, technology, product, and strategic scaling.

Company builder responsible for management and global growth, with 30+ years of leadership experience across eLearning, performance support software, and startup scaling.

Operations leader with 20 years in semiconductors, founder experience, and a track record of building production and organizational structures through company scale-up.
AI and computational engineering leader with 10+ years building AI-based solutions for aerospace, automotive, and IT, including work with global industrial partners.
Product leader with 12 years across life sciences, medical, IVD, bioinformatics, data science, and product operations for AI-driven health technology.
Scientific, mathematical, regulatory, data science, medical, and software capabilities for turning routine CBC data into a defensible platform.

Founding father of the underlying method, co-inventor, and clinical laboratory diagnostics expert with leadership experience in hospital laboratory medicine.

Mathematician focused on high-dimensional problems, combinatorics, geometry, topology, and the structures that emerge in complex data analysis.

Quality and regulatory affairs professional with EU MDR, IVDR, ISO 13485, technical documentation, clinical evidence, risk management, and QMS experience.

Data scientist with a computer engineering background, AI and cybersecurity studies, and hands-on experience with neural networks, fraud detection, forecasting, and NLP.

Human medicine student at the Medical University of Graz in cooperation with JKU Linz, bringing medical context and earlier international business training.

Full-stack developer with a biology and medical diagnostics background, focused on data-driven web applications, backend systems, and modern UI development.
Strategic, clinical cardiology, cardiovascular science, and legal/corporate guidance to strengthen evidence generation, governance, and commercialization.

Technology and business development executive with 30+ years in semiconductors and storage, including senior roles at Twist Bioscience, Western Digital, Seagate, Micron, Samsung, and others.

Professor of Internal Medicine and Cardiology at the Medical University of Graz and Head of Clinical Division of Cardiology at the University Heart Center Graz.

Corporate lawyer with more than two decades of experience across corporate law, company law, M&A, supervisory board work, and trusteeship.

Senior physician and Professor of Cardiovascular Immunology at the Medical University of Graz with scientific training across Yale, Utah, and Freiburg.
RobotDreams sits inside a European health-tech network spanning public innovation funding, clinical research, commercialization support, export expertise, and specialist life-science ecosystems.
Funding and public-support infrastructure helps de-risk the path from R&D into regulated health-tech execution.
Academic and clinical partners support the scientific grounding needed for defensible medical AI and biomarker development.
Internationalization, incubation, and commercialization partners help connect the platform to pharma, clinical, and strategic buyers.

Austrian Research Promotion Agency funding and innovation support for high-risk R&D.
Austria's federal promotional bank and public funding ecosystem for company growth.
International visibility through the Austria / Expo 2025 Osaka, Kansai, Japan ecosystem.
Clinical research and academic ecosystem around laboratory medicine, cardiology, and translational evidence.
Startup and corporate innovation ecosystem supporting commercialization and strategic market access.
Internationalization and export support from the Styrian business ecosystem.
European Space Agency commercialization ecosystem connecting deep-tech capabilities with market opportunities.
Specialist life-science cluster connecting health-tech, med-tech, pharma, and research capabilities in Styria.
Startup incubation, acceleration, and ESA BIC Austria support from the Graz innovation ecosystem.
Use the form to start a conversation with RobotDreams. Share your contact details and partnership interest, and our team will follow up directly. By submitting the form, you acknowledge the NDA terms and consent to being contacted regarding your request.
RobotDreams is building the future of precision medicine in haematology from data the healthcare system already generates.